Technology and the Life Sciences

Process analytical technology PAT for the life sciences industry

Rethinking the life sciences

Suppose that an international group of scientists presents a 15-year, €750 million research programme to unravel the molecular mechanisms of metabolic syndrome, a disorder implicated in obesity, type 2 diabetes, cardiovascular diseases, cancer and other diseases. The results from this project will neither replace obvious preventive measures—such as reducing food intake or increasing exercise—no...

[life SCIENCES]

F unctional magnetic resonance imaging (fMRI) is a noninvasive, powerful tool that has been utilized in both research and clinical arenas since the early 1990s [1] and has provided valuable insights to the understanding of the human brain function. fMRI has enabled researchers to directly study the temporal and spatial changes in the brain as a function of various stimuli. Because it relies on ...

“the effect of risk aversion on the demand for life insurance: the case of iranian life insurance market”

abstract: about 60% of total premium of insurance industry is pertained?to life policies in the world; while the life insurance total premium in iran is less than 6% of total premium in insurance industry in 2008 (sigma, no 3/2009). among the reasons that discourage the life insurance industry is the problem of adverse selection. adverse selection theory describes a situation where the inf...

Inside the triple helix: technology transfer and commercialization in the life sciences.

The transfer and subsequent application of academic research results has demonstrable benefits for health care, researchers, universities, companies, and local economies. Nonetheless, at least three general concerns exist: bias in the reporting of results, limited revenues from these activities, and the lack of data to evaluate technology transfer activities. Future efforts with regard to techn...